Difference between revisions of "Addiction WG"
From Enigma-Dev
( WorkingGroup (E) )
(CSVImport: Edit Page) |
(CSVImport: Edit Page) |
||
| Line 1: | Line 1: | ||
| − | [[Category:WorkingGroup_(E)]]{{#set: | + | [[Category:WorkingGroup_(E)]]{{#set: |
HasBriefDescription (E)=analyze data relevant to addiction phenotypes including case-control comparisons across a variety of substances.| | HasBriefDescription (E)=analyze data relevant to addiction phenotypes including case-control comparisons across a variety of substances.| | ||
HasName Full (E)=Substance Use Disorders| | HasName Full (E)=Substance Use Disorders| | ||
HasName Short (E)=Addiction| | HasName Short (E)=Addiction| | ||
HasPublishedPaper (E)=Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects and Genetic imaging consortium for addiction medicine: From neuroimaging to genes ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide}} | HasPublishedPaper (E)=Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects and Genetic imaging consortium for addiction medicine: From neuroimaging to genes ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide}} | ||
